Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Research

Post mass drug administration evaluation survey for lymphatic filariasis in Bidar district

Praveen Gowda.

Background: Lymphatic filariasis (LF) is gruesome disease which is endemic in many countries, with more than a billion people at risk of infection. In view with the global elimination, mass drug administration (MDA) with single dose of diethylcarbamazine tablets was carried out for the eligible population in Bidar district.

Aims & Objective: This study was undertaken to assess coverage of MDA against Lymphatic Filariasis in Bidar district.

Material and Methods: A cross-sectional coverage evaluation survey in one urban and three rural clusters were selected randomly in Bidar district. The data were collected in a pretested interview performa, computed and analyzed using SPSS-12.0 to calculate frequencies and proportions.

Results: A total of four clusters in the districts resulted in a study population of 642 individuals. The overall compliance rate in Bidar district was 52.18%. The prime reason for noncompliance was fear of side effects, not received tablets and not present at home.

Conclusion: There is an urgent need for more effective drug delivery strategies to improve the compliance in the district.

Key words: Mass Drug Administration, Lymphatic Filariasis, Diethylcarbamazine

Share this Article

Journal of Complementary Medicine Research


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.